Malaria Minute

Eradicating malaria by 2050 is a ‘bold but attainable goal’ according to The Lancet and ivermectin proves successful in reducing malaria transmission and killing P. falciparum parasites.

Scientists learn that a child’s immunological signature can predict whether they will develop malaria fever and the Wellcome Sanger Institute launch their Malaria Cell Atlas.

WHO announce that malaria will not be eradicated in the foreseeable future and a new study reveals drug-resistant P. falciparum parasites in every region of Africa.

World Mosquito Day celebrations take place, researchers culture malaria parasites similar to P. vivax in vitro and entomologists gather in London for the Ento ’19 scientific meeting.

The malaria outbreak in Burundi reaches epidemic proportions and the pilot implementation programme of the RTS,S vaccine begins in Kenya.

Previous estimates of malaria mortality in sub-Saharan Africa may have been underestimated and researchers in America and Germany look to nature for novel antimalarial compounds.

Researchers investigate the genes that cause insecticide resistance among malaria-carrying mosquitoes, The Global Fund launch their ‘Step Up The Fight’ awareness campaign and Alok Sharma is named as UK Secretary of State for International Development.

Drug-resistant P. falciparum spread to South East Asia, researchers at LSTM uncover the mode of action of primaquine and the International Health journal will become open-access in 2020.

Understanding human behaviour at night could reduce malaria transmission, study shows how the mosquito immune system combats malaria parasites and a researcher uncovers new insights into mosquito feeding behaviours.

The results of an extended Phase 3 RTS,S clinical trial are published in The Lancet, and researchers develop a high-tech mosquito net that monitors usage.